Aneamia - Nursing Case Study

Pathophysiology

• Primary mechanism: Reduced red blood cell production - Often due to deficiencies in essential nutrients like iron, vitamin B12, or folate, which are crucial for hematopoiesis in the bone marrow. This leads to decreased hemoglobin levels and impaired oxygen transport to tissues.

• Secondary mechanism: Increased red blood cell destruction - Conditions such as hemolytic anemia cause premature destruction of red blood cells, overwhelming the body's capacity to produce new ones, resulting in anemia.

• Key complication: Tissue hypoxia - As anemia progresses, insufficient oxygen delivery to tissues can cause fatigue, weakness, and if severe, organ dysfunction, highlighting the critical need for early diagnosis and management.

Patient Profile

Demographics:

42-year-old female, school teacher

History:

• Key past medical history: Iron deficiency anemia diagnosed 5 years ago, hypothyroidism

• Current medications: Levothyroxine 50 mcg daily, ferrous sulfate 325 mg twice daily

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Increased fatigue and shortness of breath

• Key symptoms: Persistent fatigue, dizziness, palpitations, occasional headaches, pale skin

• Vital signs: Blood pressure 100/60 mmHg, heart rate 105 bpm, respiratory rate 20 breaths per minute, temperature 98.6°F, oxygen saturation 95% on room air

Section 1

During the initial assessment, the patient, a 42-year-old female school teacher, presents with increased fatigue and shortness of breath, which she reports have progressively worsened over the past few weeks. Her clinical presentation, including persistent fatigue, dizziness, palpitations, and occasional headaches, raises concerns about the adequacy of her current anemia management. Her vital signs show a blood pressure of 100/60 mmHg, a heart rate of 105 bpm, a respiratory rate of 20 breaths per minute, and an oxygen saturation of 95% on room air. Notably, her heart rate is elevated, possibly as a compensatory mechanism for low hemoglobin levels, and her pallor suggests significant anemia.

New laboratory results reveal a hemoglobin level of 8.5 g/dL, hematocrit at 28%, and mean corpuscular volume (MCV) of 70 fL, consistent with microcytic anemia. The reticulocyte count is low, indicating insufficient bone marrow response to anemia. Iron studies show low serum ferritin and low serum iron levels, confirming the persistence of iron deficiency. However, the persistence of anemia despite ongoing iron supplementation raises the possibility of malabsorption or an underlying condition affecting iron metabolism. Additionally, thyroid function tests show slightly elevated TSH levels, suggesting suboptimal control of her hypothyroidism, which may contribute to her fatigue and should be addressed concurrently.

The patient is now experiencing moderate complications from her anemia, including tissue hypoxia, which is contributing to her symptoms and affecting her daily activities as a school teacher. This situation necessitates a more comprehensive evaluation to identify potential causes for her continued iron deficiency and to optimize her treatment plan. Further investigations, such as gastrointestinal workup for malabsorption, review of her adherence to iron therapy, and reassessment of her thyroid management, are critical steps in preventing the progression of her anemia and improving her overall quality of life.

Section 2

As the clinical team delves deeper into the underlying causes of the patient's persistent anemia, a gastrointestinal workup is initiated to assess potential malabsorption issues. An upper endoscopy and colonoscopy reveal atrophic gastritis with positive Helicobacter pylori testing, raising the concern for impaired iron absorption due to chronic inflammation of the gastric lining. The presence of H. pylori, a known contributor to iron deficiency anemia through its impact on gastric acid production, necessitates a targeted eradication therapy. This finding offers a plausible explanation for the patient's lack of response to oral iron supplementation, as the infection could be hindering adequate iron absorption.

In parallel, a comprehensive review of her medication adherence reveals that the patient has been taking her iron supplements with meals, potentially reducing their effectiveness due to interference from food components. With this insight, the healthcare team emphasizes the importance of taking iron on an empty stomach or with vitamin C to enhance absorption. Additionally, given the slightly elevated TSH levels, the patient's thyroid medication is adjusted to optimize her thyroid function, potentially alleviating some of her fatigue and enhancing her overall metabolic efficiency.

As these interventions are implemented, close monitoring of the patient's hemoglobin levels and symptoms is essential to evaluate the effectiveness of the treatment modifications. The eradication of H. pylori and improved adherence to iron supplementation are anticipated to gradually restore her iron levels, whereas the thyroid medication adjustment aims to support her energy levels and overall well-being. These steps are crucial in addressing the moderate complications of tissue hypoxia and preventing further deterioration of her condition, with the goal of improving her capacity to perform daily activities and her quality of life.

Section 3

As the treatment plan progresses, the clinical team observes the patient's response to the interventions. Two weeks after initiating H. pylori eradication therapy and adjusting her medication regimen, the patient returns for a follow-up evaluation. She reports experiencing less fatigue and an improvement in her overall energy levels, although she still has occasional episodes of lightheadedness. A physical examination reveals that her heart rate remains slightly elevated at 98 beats per minute, but her blood pressure is stable at 118/76 mmHg. Her pallor has diminished, and she appears more alert and engaged.

Laboratory tests show a modest increase in hemoglobin from 9.5 g/dL to 10.2 g/dL, suggesting that iron absorption is improving. Ferritin levels, however, remain low at 12 ng/mL, indicating ongoing iron deficiency that requires further attention. The patient's TSH level has decreased to 3.0 mIU/L, reflecting a positive response to the adjusted thyroid medication. Despite these improvements, the team notes that the patient's serum albumin is slightly decreased at 3.2 g/dL, raising concerns about potential nutritional deficiencies that may be contributing to her anemia and overall health status.

Considering these findings, the healthcare team decides to focus on optimizing the patient's nutritional status to support her recovery. A referral to a dietitian is made to assess her dietary intake and ensure she is receiving adequate nutrition, particularly protein and micronutrients essential for hematopoiesis. The team also plans to continue monitoring her hemoglobin and ferritin levels closely, with the understanding that sustained improvement in iron stores is crucial for resolving her anemia. These steps are expected to further enhance the patient's recovery and prevent any new complications from arising as she progresses on her treatment journey.

Section 4

Two weeks after the dietary intervention and continued monitoring, the patient returns for another follow-up appointment. She reports feeling more energetic and has noticed a decrease in the frequency of lightheadedness. However, she mentions new symptoms of mild swelling in her ankles and occasional shortness of breath, particularly when climbing stairs. On physical examination, her vital signs reveal a heart rate of 92 beats per minute, slightly improved from before, and her blood pressure remains stable at 115/74 mmHg. There is mild bilateral pitting edema noted in her ankles. Auscultation of her lungs reveals clear breath sounds, but the patient expresses discomfort during deep breaths, suggesting the need for further evaluation.

Laboratory results show that her hemoglobin has increased to 11.0 g/dL, indicating continued improvement in her anemia. Yet, ferritin levels remain low at 15 ng/mL, prompting the healthcare team to consider more aggressive iron supplementation strategies. Her serum albumin has decreased further to 2.9 g/dL, raising additional concerns about her nutritional status and potential protein deficiency. The team suspects that the edema may be related to hypoalbuminemia, leading to the decision to perform additional diagnostics, including a complete metabolic panel and a renal function test, to rule out other potential causes such as renal impairment or cardiac dysfunction.

Given these findings, the clinical team emphasizes the importance of addressing her nutritional deficiencies more effectively. The dietitian collaborates with the patient to ensure adherence to a diet rich in high-quality protein and essential micronutrients. Additionally, the healthcare team plans to reassess her current medications to identify any contributing factors to her symptoms. This approach aims to stabilize her condition, promote further recovery, and prevent the development of more severe complications. The team sets a follow-up appointment for two weeks to monitor her progress and adjust her treatment plan as necessary.

Section 5

Two weeks later, the patient returns for her follow-up appointment. She reports that while she feels slightly more energetic, her shortness of breath has become more pronounced, particularly during moderate physical activity, such as walking around her home. She also notes an increase in ankle swelling and now experiences mild swelling in her hands. On examination, her vital signs show a heart rate of 98 beats per minute and blood pressure slightly elevated at 126/80 mmHg. The bilateral pitting edema in her ankles has progressed to a 2+ level, and there is additional mild edema in her hands. Lung auscultation reveals slight wheezing at the bases, and she continues to experience discomfort on deep inspiration.

The recently performed diagnostic tests indicate a mild worsening in her renal function, with her glomerular filtration rate (GFR) decreasing to 58 mL/min/1.73m². Her complete metabolic panel reveals a further decrease in serum albumin to 2.7 g/dL, reinforcing concerns about her nutritional status and possible protein-energy malnutrition. Electrolyte levels remain within normal ranges, but a slight hyperkalemia is noted with a potassium level of 5.4 mEq/L. These findings suggest that her edema may be multifactorial, involving both hypoalbuminemia and early signs of renal impairment, necessitating a thorough review of her dietary intake and potentially nephrotoxic medications.

Given the new complications, the healthcare team discusses the need to intensify her nutritional therapy with a focus on protein intake while carefully managing her electrolyte balance and monitoring potential impacts on renal function. The patient's current medications are re-evaluated to identify any agents that could contribute to her renal decline or electrolyte imbalance. The team also considers the introduction of diuretics to manage her edema, weighing the benefits against the risk of further electrolyte disturbances. With these strategies, the focus remains on stabilizing her condition, preventing the progression of renal impairment, and addressing nutritional deficiencies to improve her overall health and prevent further complications. A follow-up is scheduled in one week to closely monitor her response to these interventions and adjust her treatment plan accordingly.